Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05405595 |
|---|---|
| Brief Title: | ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors |
| First Submitted : | May 16, 2022 |
| First Submitted that Met QC Criteria : | June 2, 2022 |
| First Posted : | June 6, 2022 |
| Last Update Submitted that Met QC Criteria : | February 23, 2024 |
| Last Update Posted : | February 26, 2024 |